Diffuse Bio

San Francisco, United States

Diffuse Bio develops an automated AI software platform for drug design, leveraging advances in generative AI.

$500K raised

Apr 2023

Pre-Seed

Top Investors

Y CombinatorFellows Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Diffuse Bio raised?

Diffuse Bio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.

Who are Diffuse Bio's investors?

Diffuse Bio's investors include Y Combinator, Fellows Fund.

Where is Diffuse Bio headquartered?

Diffuse Bio is headquartered in San Francisco, United States.

What does Diffuse Bio do?

Diffuse Bio develops an automated AI software platform for drug design, leveraging advances in generative AI.

What stage is Diffuse Bio at?

Diffuse Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 5, 2023.

MLA

"Diffuse Bio — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/diffuse-bio. Accessed July 1, 2026.

APA

VCBacked. (2023). Diffuse Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/diffuse-bio

Wikipedia (cite web)

{{cite web |title=Diffuse Bio — Funding & Investors |url=https://www.vcbacked.co/company/diffuse-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 5, 2023.